JBT Marel Q2 Revenue Misses Slightly, Adjusted EPS Beats; Guidance Reiterated
JBTM sits 25% above its 52-week low of $113.67.
Summary
JBT Marel's Q2 revenue of $981M missed consensus by a hair, but adjusted EPS of $1.95 beat estimates. Full-year guidance was reiterated, and orders remained strong with a 1.05x book-to-bill ratio.
Key Events · Earnings and Guidance · JBTM
-
Q2 Revenue Slightly Below Consensus
Revenue of $981 million increased 5% year-over-year but fell short of the $988.47 million consensus estimate.
-
Adjusted EPS Beats, GAAP EPS Impacted by Impairment
Adjusted EPS of $1.95 exceeded the prior year's $1.49, while GAAP EPS of $0.54 included a $33 million non-cash impairment charge.
-
Full-Year Guidance Reiterated
Management reaffirmed 2026 revenue guidance of $3.99-$4.065 billion and adjusted EBITDA margin of 17.0%-17.5%, with adjusted EPS refined to $7.85-$8.35.
-
Strong Orders and Backlog
Orders exceeded $1 billion, yielding a book-to-bill ratio of 1.05x, and quarter-ending backlog reached a record $1.54 billion.
Analysis · JBTM · Technology
JBT Marel reported Q2 revenue of $981 million, up 5% year-over-year but just shy of the $988.47 million consensus. Adjusted EPS of $1.95 beat the $1.49 from a year ago, driven by strong orders and margin improvement. The company reiterated its full-year revenue and adjusted EBITDA guidance, signaling confidence in the second half despite near-term operational headwinds. A $33 million non-cash impairment charge weighed on GAAP earnings, but the underlying business momentum—with a book-to-bill above 1.0x and record backlog—supports the outlook. The stock may react to the slight top-line miss, but the reaffirmed guidance and solid order book are the key takeaways.
At the time of this filing, JBTM was trading at $142.25 on NYSE in the Technology sector, with a market capitalization of approximately $7.4B. The 52-week trading range was $113.67 to $170.19. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.